Skip to main content
. 2018 Apr;4(2):a002089. doi: 10.1101/mcs.a002089

Table 2.

Descriptions of the genomic breakpoints for the patients provided by Foundation Medicine, Inc.

Disease ontologya Genomic breakpoints
Uterus endometrial adenocarcinoma (NOS) Chr 4 duplication fragment: 5′-FGFR3(ex1-18 UTR NM_000142)-TACC3(ex10-16 NM_006342) Breakpoints FGFR3 exon 18, TACC3 intron 9
aUterus endometrial adenocarcinoma (NOS) Chr 4 duplication fragment: 5′-FGFR3(ex1-17 NM_000142)-TACC3(ex8-16 NM_006342) Breakpoints FGFR3 exon 17, TACC3 exon 8
Uterus endometrial adenocarcinoma clear cell Chr 4 duplication fragment: 5′-FGFR3(ex1-2 NM_000142)-TACC3(ex7-16 NM_006342) Breakpoints FGFR3 exon 2, TACC3 intron 6
Uterus endometrial adenocarcinoma papillary serous Chr 4 duplication fragment: 5′-FGFR3(ex1-18 UTR NM_000142)-TACC3(ex10-16 NM_006342) Breakpoints FGFR3 exon 18, TACC3 intron 9

aHighlighted case results.